Gout & crystal arthritis

Gout and Excess Risk of Severe SARS–CoV‐2 Infection Among Vaccinated Individuals: A General Population Study

Arthritis RheumatolPublished Cohort study

Authors' conclusion

These general population data suggest that individuals with gout, especially women, have higher risks of SARS-CoV-2 infection and severe outcomes, even when vaccinated.

Study context

Population
General population, The Health Improvement Network, UK, followed from December 8, 2020 to October 31, 2021; vaccinated and unvaccinated cohortsvaccinated cohort
Participants
54,576 vs 1,336,377
Exposure
Individuals with gout vs those without gout, by SARS-CoV-2 vaccination status
  • Goutn = 54,576
  • Without goutn = 1,336,377reference
Outcome
SARS-CoV-2 (breakthrough) infection and severe outcomes (hospitalization and death within 30 days after infection)
Methodological details2 cohort studies, overlap weighting of exposure scores, Cox proportional hazards model
  • 2 cohort studies
  • Overlap weighting of exposure scores
  • Cox proportional hazards model

Main finding

As reported in the abstract

Breakthrough COVID-19 infection (vaccinated cohort)
Partially adjusted rate difference (RD) of breakthrough infection, gout vs without gout
0.91 cases per 1,000 person-months (95% CI 0.62-1.20 cases per 1,000 person-months)
Partially adjusted HR of breakthrough infection, gout vs without gout
1.24 (95% CI 1.19-1.30)

Observational data: associations, not effects.

Further findings

OutcomeaHR (95% CI)
Hospitalization, vaccinated cohort · within 30 days after infection1.30 (1.10–1.53)
Death, vaccinated cohort · within 30 days after infection1.36 (0.87–2.13)
Hospitalization in women (subgroup)1.55 (1.15–2.10)
Death in women (subgroup)2.46 (1.12–5.41)

Unvaccinated cohort

Similar associations with gout were observed in the unvaccinated cohort

Original publication

Gout and Excess Risk of Severe SARS–CoV‐2 Infection Among Vaccinated Individuals: A General Population Study. Arthritis Rheumatol. Published 30 November 2022. doi:10.1002/art.42339

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.